Moderna begin human trials of mRNA-based flu shot

New York, Jul 8 (IANS): US-based biotechnology company Moderna on Wednesday announced that it has started human trials of an mRNA-based flu shot.

The pharmaceutical giant said the first participants have been dosed in the Phase 1/2 study of mRNA-1010, the company's quadrivalent seasonal influenza mRNA vaccine candidate.

"We are pleased to have begun this Phase 1/2 study of mRNA-1010, our first mRNA seasonal flu vaccine candidate to enter the clinic," Stephane Bancel, Chief Executive Officer of Moderna, said in a statement.

"We expect that our seasonal influenza vaccine candidates will be an important component of our future combination respiratory vaccines," Bancel added.

This Phase 1/2 randomised, stratified, observer-blind, the dose-ranging study will evaluate the safety, reactogenicity and immunogenicity of mRNA-1010, Moderna's seasonal influenza vaccine candidate in healthy adults 18 years and older in the US.

The company said it intends to enroll approximately 180 participants in the study.

mRNA-1010 is Moderna's first seasonal influenza vaccine candidate to enter the clinic and targets lineages recommended by the World Health Organization (WHO) for the prevention of influenza, including seasonal influenza A H1N1, H3N2 and influenza B Yamagata and Victoria.

Seasonal flu (type A and type B) epidemics occur seasonally and vary in severity each year, causing respiratory illnesses and placing a substantial burden on healthcare systems.

The WHO estimates approximately 3-5 million severe cases of flu each year globally, and 290,000 to 650,000 flu-related respiratory deaths.

Approximately 8 per cent of the US population experiences symptoms from flu each year. In the US, the estimated average economic burden of flu is approximately $11 billion per year.



Top Stories

Leave a Comment

Title: Moderna begin human trials of mRNA-based flu shot

You have 2000 characters left.


Please write your correct name and email address. Kindly do not post any personal, abusive, defamatory, infringing, obscene, indecent, discriminatory or unlawful or similar comments. will not be responsible for any defamatory message posted under this article.

Please note that sending false messages to insult, defame, intimidate, mislead or deceive people or to intentionally cause public disorder is punishable under law. It is obligatory on Daijiworld to provide the IP address and other details of senders of such comments, to the authority concerned upon request.

Hence, sending offensive comments using daijiworld will be purely at your own risk, and in no way will be held responsible.

Security Validation

Enter the characters in the image